会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 39. 发明申请
    • ANTIDIABETIC AGENTS
    • 抗真菌剂
    • WO2005100331A3
    • 2006-04-06
    • PCT/IB2005000998
    • 2005-04-14
    • RANBAXY LAB LTDSALMAN MOHAMMADSATTIGERI JITENDRAVIR DHARAMGANGAN VIJA DATTATRAYA
    • SALMAN MOHAMMADSATTIGERI JITENDRAVIR DHARAMGANGAN VIJA DATTATRAYA
    • A61K31/427A61P3/10C07D277/20C07D277/34C07D417/10C07D417/12
    • C07D277/20C07D277/34C07D417/10C07D417/12
    • The present invention relates to alkynyl derivatives, which have PPAR agonist activity and hence can be used as antidiabetic compounds. Compounds disclosed herein can be used for the treatment of diabetes and diabetes-associated complications, for the treatment of diseases and conditions in which insulin resistance is the central pathophysiological mechanism, for the treatment of diseases or conditions such as Type II diabetes, dyslipidaemia, hypertension, coronary heart disease, cardiovascular disease, atherosclerosis, diabetes nephropathy, glomerulonephritis, glomerularsclerosis, nephrotic syndorme, hypertensive nephrosclerosis, polycystic ovarian syndrome, eating disorders, psoriasis, obesity, for improving cognitive functions in dementia and as aldose reductase inhibitors. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diabetes mellitus and the diseases and conditions mediated through insulin resistance are provided.
    • 本发明涉及具有PPAR激动剂活性的炔基衍生物,因此可用作抗糖尿病化合物。 本文公开的化合物可用于治疗糖尿病和糖尿病相关并发症,用于治疗其中胰岛素抵抗是中枢病理机制的疾病和病症,用于治疗疾病或病症如II型糖尿病,血脂异常,高血压 冠心病,心血管疾病,动脉粥样硬化,糖尿病肾病,肾小球肾炎,肾小球硬化症,肾病综合征,高血压性肾硬化,多囊卵巢综合征,进食障碍,牛皮癣,肥胖症,用于改善痴呆症中的认知功能和作为醛糖还原酶抑制剂。 提供了制备所公开化合物的方法,含有所公开化合物的药物组合物,以及治疗糖尿病的方法以及通过胰岛素抵抗介导的疾病和病症。